Any early-onset non-syndromic cataract in which the cause of the disease is a mutation in the GJA3 gene.
Comprehensive, easy-to-understand information about this condition
How we create this content →The documentation surrounding cataract 14 multiple types is limited due to the rarity of the condition, which affects fewer individuals than larger studies can typically accommodate. Additionally, the genetic basis was only recently identified, leading to ongoing efforts to characterize its clinical features and implications. This means that while you may feel isolated, you are not alone in seeking answers.
To navigate your condition effectively, consider consulting with an ophthalmologist who specializes in genetic eye disorders, particularly those with experience in cataracts. Additionally, genetic counseling may be beneficial to understand the implications of the GJA3 mutation for you and your family. While no patient organizations have been identified, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and support.
Currently, there is one active clinical trial related to cataract 14 multiple types. This trial may provide opportunities for participation and contribute to the understanding of the condition. For more information, you can search for ongoing studies at ClinicalTrials.gov using the following link: https://clinicaltrials.gov/search?cond=cataract%2014%20multiple%20types.
Actionable guidance for navigating care for cataract 14 multiple types
To navigate your condition effectively, consider consulting with an ophthalmologist who specializes in genetic eye disorders, particularly those with experience in cataracts. Additionally, genetic counseling may be beneficial to understand the implications of the GJA3 mutation for you and your family. While no patient organizations have been identified, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and support.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation surrounding cataract 14 multiple types is limited due to the rarity of the condition, which affects fewer individuals than larger studies can typically accommodate. Additionally, the genetic basis was only recently identified, leading to ongoing efforts to characterize its clinical features and implications. This means that while you may feel isolated, you are not alone in seeking answers.
To navigate your condition effectively, consider consulting with an ophthalmologist who specializes in genetic eye disorders, particularly those with experience in cataracts. Additionally, genetic counseling may be beneficial to understand the implications of the GJA3 mutation for you and your family. While no patient organizations have been identified, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and support.
Currently, there is one active clinical trial related to cataract 14 multiple types. This trial may provide opportunities for participation and contribute to the understanding of the condition. For more information, you can search for ongoing studies at ClinicalTrials.gov using the following link: https://clinicaltrials.gov/search?cond=cataract%2014%20multiple%20types.
Actionable guidance for navigating care for cataract 14 multiple types
To navigate your condition effectively, consider consulting with an ophthalmologist who specializes in genetic eye disorders, particularly those with experience in cataracts. Additionally, genetic counseling may be beneficial to understand the implications of the GJA3 mutation for you and your family. While no patient organizations have been identified, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and support.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation surrounding cataract 14 multiple types is limited due to the rarity of the condition, which affects fewer individuals than larger studies can typically accommodate. Additionally, the genetic basis was only recently identified, leading to ongoing efforts to characterize its clinical features and implications. This means that while you may feel isolated, you are not alone in seeking answers.
To navigate your condition effectively, consider consulting with an ophthalmologist who specializes in genetic eye disorders, particularly those with experience in cataracts. Additionally, genetic counseling may be beneficial to understand the implications of the GJA3 mutation for you and your family. While no patient organizations have been identified, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and support.
Currently, there is one active clinical trial related to cataract 14 multiple types. This trial may provide opportunities for participation and contribute to the understanding of the condition. For more information, you can search for ongoing studies at ClinicalTrials.gov using the following link: https://clinicaltrials.gov/search?cond=cataract%2014%20multiple%20types.
Actionable guidance for navigating care for cataract 14 multiple types
To navigate your condition effectively, consider consulting with an ophthalmologist who specializes in genetic eye disorders, particularly those with experience in cataracts. Additionally, genetic counseling may be beneficial to understand the implications of the GJA3 mutation for you and your family. While no patient organizations have been identified, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and support.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 7, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.